L-NAME prevents anxiety-like and depression-like behavior in rats exposed to restraint stress

Stressful life events contribute to the development of many neuropsychiatric disorders including depression and anxiety. Animal studies based on the relationship of stress and depression or anxiety are scarce and controversial. Moreover, neither the neurobiological basis of anxiety and depression no...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Methods and Findings in Experimental and Clinical Pharmacology 2006-03, Vol.28 (2), p.95-99
Hauptverfasser: SEVGI, S, ÖZEK, M, EROGLU, L
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page 99
container_issue 2
container_start_page 95
container_title Methods and Findings in Experimental and Clinical Pharmacology
container_volume 28
creator SEVGI, S
ÖZEK, M
EROGLU, L
description Stressful life events contribute to the development of many neuropsychiatric disorders including depression and anxiety. Animal studies based on the relationship of stress and depression or anxiety are scarce and controversial. Moreover, neither the neurobiological basis of anxiety and depression nor the mechanisms responsible for neurochemical regulation by stressful stimuli are well understood. This study was designed to investigate the possible contribution of both acute (2 h) and chronic (2 h X 15 d) restraint stress in the generation of anxiety and depression, and also to find out whether nitric oxide (NO) has a modulatory role in these behavioral reactions. Elevated plus-maze and forced swimming test (FST) were chosen for assessment of anxiety and depression, respectively, and N(G)-nitro L-arginine methyl ester (L-NAME, 10 mg/kg), a NO synthase (NOS) inhibitor, and L-arginine (50 mg/kg), a NO precursor, were used to evaluate the role of nitrergic system in restraint exposed rats. The results showed that acute and chronic stress caused depression-like and anxiety-like behaviors in rats and the acute inhibition of NOS by L-NAME prevented these acute and chronic stress-induced anxiogenesis and depression. These data lead to the conclusion that stress and NO seem to be involved in the generation of anxiety and depression.
doi_str_mv 10.1358/mf.2006.28.2.977840
format Article
fullrecord <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_67897486</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>67897486</sourcerecordid><originalsourceid>FETCH-LOGICAL-c333t-b93e6f485a850611eca0561cc9d0c31771ab7c57f00d893876f5ba6104bd7d5a3</originalsourceid><addsrcrecordid>eNpFkElPwzAQhX0A0VL4BUgoF7gl2HG85FhVZZEKXOCILMeLMGTDTqv23-MqkXp6mpnvPY0eADcIZggT_tDYLIeQZjnP8qxkjBfwDMwhZmUKMSEzcBnCD4Q5IphcgBmiFFOGyjn42qRvy9d10nuzM-0QEtnunRkOae1-TRx0ok28heC6dtxV5lvuXOcT1yZeRofZ910wOhm6JIKDl64dkqjRdAXOrayDuZ50AT4f1x-r53Tz_vSyWm5ShTEe0qrEhtqCE8kJpAgZJSGhSKlSQ4URY0hWTBFmIdS8xJxRSypJESwqzTSReAHux9zed3_b-IRoXFCmrmVrum0QlPGSFZxGEI-g8l0I3ljRe9dIfxAIimOTorHi2KTIucjF2GR03U7x26ox-uSZaozA3QTIoGRtvWyVCyeOMZwjhPE_tWR-1Q</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>67897486</pqid></control><display><type>article</type><title>L-NAME prevents anxiety-like and depression-like behavior in rats exposed to restraint stress</title><source>MEDLINE</source><source>Portico (Triggered Content) Journals</source><creator>SEVGI, S ; ÖZEK, M ; EROGLU, L</creator><creatorcontrib>SEVGI, S ; ÖZEK, M ; EROGLU, L</creatorcontrib><description>Stressful life events contribute to the development of many neuropsychiatric disorders including depression and anxiety. Animal studies based on the relationship of stress and depression or anxiety are scarce and controversial. Moreover, neither the neurobiological basis of anxiety and depression nor the mechanisms responsible for neurochemical regulation by stressful stimuli are well understood. This study was designed to investigate the possible contribution of both acute (2 h) and chronic (2 h X 15 d) restraint stress in the generation of anxiety and depression, and also to find out whether nitric oxide (NO) has a modulatory role in these behavioral reactions. Elevated plus-maze and forced swimming test (FST) were chosen for assessment of anxiety and depression, respectively, and N(G)-nitro L-arginine methyl ester (L-NAME, 10 mg/kg), a NO synthase (NOS) inhibitor, and L-arginine (50 mg/kg), a NO precursor, were used to evaluate the role of nitrergic system in restraint exposed rats. The results showed that acute and chronic stress caused depression-like and anxiety-like behaviors in rats and the acute inhibition of NOS by L-NAME prevented these acute and chronic stress-induced anxiogenesis and depression. These data lead to the conclusion that stress and NO seem to be involved in the generation of anxiety and depression.</description><identifier>ISSN: 0379-0355</identifier><identifier>ISSN: 2013-0155</identifier><identifier>DOI: 10.1358/mf.2006.28.2.977840</identifier><identifier>PMID: 16636719</identifier><language>eng</language><publisher>Barcelona: Prous</publisher><subject>Acute Disease ; Animals ; Anxiety - etiology ; Anxiety - prevention &amp; control ; Arginine - pharmacology ; Biological and medical sciences ; Chronic Disease ; Depression - etiology ; Depression - prevention &amp; control ; Disease Models, Animal ; Dose-Response Relationship, Drug ; General pharmacology ; Male ; Medical sciences ; NG-Nitroarginine Methyl Ester - administration &amp; dosage ; NG-Nitroarginine Methyl Ester - pharmacology ; Nitric Oxide - biosynthesis ; Nitric Oxide Synthase - antagonists &amp; inhibitors ; Pharmaceutical technology. Pharmaceutical industry ; Pharmacology. Drug treatments ; Rats ; Rats, Wistar ; Restraint, Physical ; Stress, Psychological - complications</subject><ispartof>Methods and Findings in Experimental and Clinical Pharmacology, 2006-03, Vol.28 (2), p.95-99</ispartof><rights>2006 INIST-CNRS</rights><rights>(c) 2006 Prous Science. All rights reserved.</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c333t-b93e6f485a850611eca0561cc9d0c31771ab7c57f00d893876f5ba6104bd7d5a3</citedby></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,776,780,27901,27902</link.rule.ids><backlink>$$Uhttp://pascal-francis.inist.fr/vibad/index.php?action=getRecordDetail&amp;idt=17732113$$DView record in Pascal Francis$$Hfree_for_read</backlink><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/16636719$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>SEVGI, S</creatorcontrib><creatorcontrib>ÖZEK, M</creatorcontrib><creatorcontrib>EROGLU, L</creatorcontrib><title>L-NAME prevents anxiety-like and depression-like behavior in rats exposed to restraint stress</title><title>Methods and Findings in Experimental and Clinical Pharmacology</title><addtitle>Methods Find Exp Clin Pharmacol</addtitle><description>Stressful life events contribute to the development of many neuropsychiatric disorders including depression and anxiety. Animal studies based on the relationship of stress and depression or anxiety are scarce and controversial. Moreover, neither the neurobiological basis of anxiety and depression nor the mechanisms responsible for neurochemical regulation by stressful stimuli are well understood. This study was designed to investigate the possible contribution of both acute (2 h) and chronic (2 h X 15 d) restraint stress in the generation of anxiety and depression, and also to find out whether nitric oxide (NO) has a modulatory role in these behavioral reactions. Elevated plus-maze and forced swimming test (FST) were chosen for assessment of anxiety and depression, respectively, and N(G)-nitro L-arginine methyl ester (L-NAME, 10 mg/kg), a NO synthase (NOS) inhibitor, and L-arginine (50 mg/kg), a NO precursor, were used to evaluate the role of nitrergic system in restraint exposed rats. The results showed that acute and chronic stress caused depression-like and anxiety-like behaviors in rats and the acute inhibition of NOS by L-NAME prevented these acute and chronic stress-induced anxiogenesis and depression. These data lead to the conclusion that stress and NO seem to be involved in the generation of anxiety and depression.</description><subject>Acute Disease</subject><subject>Animals</subject><subject>Anxiety - etiology</subject><subject>Anxiety - prevention &amp; control</subject><subject>Arginine - pharmacology</subject><subject>Biological and medical sciences</subject><subject>Chronic Disease</subject><subject>Depression - etiology</subject><subject>Depression - prevention &amp; control</subject><subject>Disease Models, Animal</subject><subject>Dose-Response Relationship, Drug</subject><subject>General pharmacology</subject><subject>Male</subject><subject>Medical sciences</subject><subject>NG-Nitroarginine Methyl Ester - administration &amp; dosage</subject><subject>NG-Nitroarginine Methyl Ester - pharmacology</subject><subject>Nitric Oxide - biosynthesis</subject><subject>Nitric Oxide Synthase - antagonists &amp; inhibitors</subject><subject>Pharmaceutical technology. Pharmaceutical industry</subject><subject>Pharmacology. Drug treatments</subject><subject>Rats</subject><subject>Rats, Wistar</subject><subject>Restraint, Physical</subject><subject>Stress, Psychological - complications</subject><issn>0379-0355</issn><issn>2013-0155</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2006</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNpFkElPwzAQhX0A0VL4BUgoF7gl2HG85FhVZZEKXOCILMeLMGTDTqv23-MqkXp6mpnvPY0eADcIZggT_tDYLIeQZjnP8qxkjBfwDMwhZmUKMSEzcBnCD4Q5IphcgBmiFFOGyjn42qRvy9d10nuzM-0QEtnunRkOae1-TRx0ok28heC6dtxV5lvuXOcT1yZeRofZ910wOhm6JIKDl64dkqjRdAXOrayDuZ50AT4f1x-r53Tz_vSyWm5ShTEe0qrEhtqCE8kJpAgZJSGhSKlSQ4URY0hWTBFmIdS8xJxRSypJESwqzTSReAHux9zed3_b-IRoXFCmrmVrum0QlPGSFZxGEI-g8l0I3ljRe9dIfxAIimOTorHi2KTIucjF2GR03U7x26ox-uSZaozA3QTIoGRtvWyVCyeOMZwjhPE_tWR-1Q</recordid><startdate>20060301</startdate><enddate>20060301</enddate><creator>SEVGI, S</creator><creator>ÖZEK, M</creator><creator>EROGLU, L</creator><general>Prous</general><scope>IQODW</scope><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope></search><sort><creationdate>20060301</creationdate><title>L-NAME prevents anxiety-like and depression-like behavior in rats exposed to restraint stress</title><author>SEVGI, S ; ÖZEK, M ; EROGLU, L</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c333t-b93e6f485a850611eca0561cc9d0c31771ab7c57f00d893876f5ba6104bd7d5a3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2006</creationdate><topic>Acute Disease</topic><topic>Animals</topic><topic>Anxiety - etiology</topic><topic>Anxiety - prevention &amp; control</topic><topic>Arginine - pharmacology</topic><topic>Biological and medical sciences</topic><topic>Chronic Disease</topic><topic>Depression - etiology</topic><topic>Depression - prevention &amp; control</topic><topic>Disease Models, Animal</topic><topic>Dose-Response Relationship, Drug</topic><topic>General pharmacology</topic><topic>Male</topic><topic>Medical sciences</topic><topic>NG-Nitroarginine Methyl Ester - administration &amp; dosage</topic><topic>NG-Nitroarginine Methyl Ester - pharmacology</topic><topic>Nitric Oxide - biosynthesis</topic><topic>Nitric Oxide Synthase - antagonists &amp; inhibitors</topic><topic>Pharmaceutical technology. Pharmaceutical industry</topic><topic>Pharmacology. Drug treatments</topic><topic>Rats</topic><topic>Rats, Wistar</topic><topic>Restraint, Physical</topic><topic>Stress, Psychological - complications</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>SEVGI, S</creatorcontrib><creatorcontrib>ÖZEK, M</creatorcontrib><creatorcontrib>EROGLU, L</creatorcontrib><collection>Pascal-Francis</collection><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><jtitle>Methods and Findings in Experimental and Clinical Pharmacology</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>SEVGI, S</au><au>ÖZEK, M</au><au>EROGLU, L</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>L-NAME prevents anxiety-like and depression-like behavior in rats exposed to restraint stress</atitle><jtitle>Methods and Findings in Experimental and Clinical Pharmacology</jtitle><addtitle>Methods Find Exp Clin Pharmacol</addtitle><date>2006-03-01</date><risdate>2006</risdate><volume>28</volume><issue>2</issue><spage>95</spage><epage>99</epage><pages>95-99</pages><issn>0379-0355</issn><issn>2013-0155</issn><abstract>Stressful life events contribute to the development of many neuropsychiatric disorders including depression and anxiety. Animal studies based on the relationship of stress and depression or anxiety are scarce and controversial. Moreover, neither the neurobiological basis of anxiety and depression nor the mechanisms responsible for neurochemical regulation by stressful stimuli are well understood. This study was designed to investigate the possible contribution of both acute (2 h) and chronic (2 h X 15 d) restraint stress in the generation of anxiety and depression, and also to find out whether nitric oxide (NO) has a modulatory role in these behavioral reactions. Elevated plus-maze and forced swimming test (FST) were chosen for assessment of anxiety and depression, respectively, and N(G)-nitro L-arginine methyl ester (L-NAME, 10 mg/kg), a NO synthase (NOS) inhibitor, and L-arginine (50 mg/kg), a NO precursor, were used to evaluate the role of nitrergic system in restraint exposed rats. The results showed that acute and chronic stress caused depression-like and anxiety-like behaviors in rats and the acute inhibition of NOS by L-NAME prevented these acute and chronic stress-induced anxiogenesis and depression. These data lead to the conclusion that stress and NO seem to be involved in the generation of anxiety and depression.</abstract><cop>Barcelona</cop><pub>Prous</pub><pmid>16636719</pmid><doi>10.1358/mf.2006.28.2.977840</doi><tpages>5</tpages></addata></record>
fulltext fulltext
identifier ISSN: 0379-0355
ispartof Methods and Findings in Experimental and Clinical Pharmacology, 2006-03, Vol.28 (2), p.95-99
issn 0379-0355
2013-0155
language eng
recordid cdi_proquest_miscellaneous_67897486
source MEDLINE; Portico (Triggered Content) Journals
subjects Acute Disease
Animals
Anxiety - etiology
Anxiety - prevention & control
Arginine - pharmacology
Biological and medical sciences
Chronic Disease
Depression - etiology
Depression - prevention & control
Disease Models, Animal
Dose-Response Relationship, Drug
General pharmacology
Male
Medical sciences
NG-Nitroarginine Methyl Ester - administration & dosage
NG-Nitroarginine Methyl Ester - pharmacology
Nitric Oxide - biosynthesis
Nitric Oxide Synthase - antagonists & inhibitors
Pharmaceutical technology. Pharmaceutical industry
Pharmacology. Drug treatments
Rats
Rats, Wistar
Restraint, Physical
Stress, Psychological - complications
title L-NAME prevents anxiety-like and depression-like behavior in rats exposed to restraint stress
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-28T18%3A11%3A27IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=L-NAME%20prevents%20anxiety-like%20and%20depression-like%20behavior%20in%20rats%20exposed%20to%20restraint%20stress&rft.jtitle=Methods%20and%20Findings%20in%20Experimental%20and%20Clinical%20Pharmacology&rft.au=SEVGI,%20S&rft.date=2006-03-01&rft.volume=28&rft.issue=2&rft.spage=95&rft.epage=99&rft.pages=95-99&rft.issn=0379-0355&rft_id=info:doi/10.1358/mf.2006.28.2.977840&rft_dat=%3Cproquest_cross%3E67897486%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=67897486&rft_id=info:pmid/16636719&rfr_iscdi=true